• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氢吗啡酮-3-葡萄糖醛酸苷:生化合成及初步药理学评价。

Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation.

作者信息

Wright A W, Nocente M L, Smith M T

机构信息

School of Pharmacy, The University of Queensland, Brisbane, Australia.

出版信息

Life Sci. 1998;63(5):401-11. doi: 10.1016/s0024-3205(98)00288-4.

DOI:10.1016/s0024-3205(98)00288-4
PMID:9714427
Abstract

Hydromorphone-3-glucuronide (H3G) was synthesized biochemically using rat liver microsomes, uridine-5'-diphosphoglucuronic acid (UDPGA) and the substrate, hydromorphone. Initially, the crude putative H3G product was purified by ethyl acetate precipitation and washing with acetonitrile. Final purification was achieved using semi-preparative high-performance-liquid-chromatography (HPLC) with ultraviolet (UV) detection. The purity of the final H3G product was shown by HPLC with electrochemical and ultraviolet detection to be > 99.9% and it was produced in a yield of = 60% (on a molar basis). The chemical structure of the putative H3G was confirmed by enzymatic hydrolysis of the glucuronide moiety using beta-glucuronidase, producing a hydrolysis product with the same HPLC retention time as the hydromorphone reference standard. Using HPLC with tandem mass spectrometry (HPLC-MS-MS) in the positive ionization mode, the molecular mass (M+1) was found to be 462 g/mol, in agreement with H3G's expected molecular weight of 461 g/mol. Importantly, proton-NMR indicated that the glucuronide moiety was attached at the 3-phenolic position of hydromorphone. A preliminary evaluation of H3G's intrinsic pharmacological effects revealed that following i.c.v. administration to adult male Sprague-Dawley rats in a dose of 5 microg, H3G evoked a range of excitatory behavioural effects including chewing, rearing, myoclonus, ataxia and tonic-clonic convulsions, in a manner similar to that reported previously for the glucuronide metabolites of morphine, morphine-3-glucuronide and normorphine-3-glucuronide.

摘要

使用大鼠肝微粒体、尿苷-5'-二磷酸葡萄糖醛酸(UDPGA)和底物氢吗啡酮通过生化方法合成了氢吗啡酮-3-葡萄糖醛酸苷(H3G)。最初,通过乙酸乙酯沉淀并用乙腈洗涤对粗制的假定H3G产物进行纯化。使用具有紫外(UV)检测的半制备高效液相色谱(HPLC)实现最终纯化。通过具有电化学和紫外检测的HPLC显示,最终H3G产物的纯度>99.9%,并且其产率为60%(基于摩尔)。使用β-葡萄糖醛酸苷酶对葡萄糖醛酸苷部分进行酶促水解,产生一种水解产物,其HPLC保留时间与氢吗啡酮参考标准品相同,从而证实了假定H3G的化学结构。在正离子模式下使用HPLC串联质谱(HPLC-MS-MS),发现分子量(M+1)为462 g/mol,与H3G预期分子量461 g/mol一致。重要的是,质子核磁共振表明葡萄糖醛酸苷部分连接在氢吗啡酮的3-酚羟基位置。对H3G内在药理作用的初步评估显示,以5微克的剂量对成年雄性Sprague-Dawley大鼠进行脑室内给药后,H3G引发了一系列兴奋性行为效应,包括咀嚼、竖毛、肌阵挛、共济失调和强直性阵挛性惊厥,其方式与先前报道的吗啡的葡萄糖醛酸苷代谢物、吗啡-3-葡萄糖醛酸苷和去甲吗啡-3-葡萄糖醛酸苷相似。

相似文献

1
Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation.氢吗啡酮-3-葡萄糖醛酸苷:生化合成及初步药理学评价。
Life Sci. 1998;63(5):401-11. doi: 10.1016/s0024-3205(98)00288-4.
2
Biochemical synthesis, purification and preliminary pharmacological evaluation of normorphine-3-glucuronide.
Life Sci. 1997;61(2):95-104. doi: 10.1016/s0024-3205(97)00364-0.
3
Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide.
Life Sci. 2001 Jun 15;69(4):409-20. doi: 10.1016/s0024-3205(01)01133-x.
4
Identification and synthesis of norhydromorphone, and determination of antinociceptive activities in the rat formalin test.
Life Sci. 2004 Nov 12;75(26):3129-46. doi: 10.1016/j.lfs.2004.06.008.
5
Correlation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: a pilot study.
J Opioid Manag. 2010 Mar-Apr;6(2):87-94. doi: 10.5055/jom.2010.0008.
6
Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites.吗啡和氢吗啡酮的神经兴奋作用:涉及3-葡萄糖醛酸代谢物的证据。
Clin Exp Pharmacol Physiol. 2000 Jul;27(7):524-8. doi: 10.1046/j.1440-1681.2000.03290.x.
7
LC-MS-MS analysis of hydromorphone and hydromorphone metabolites with application to a pharmacokinetic study in the male Sprague-Dawley rat.氢吗啡酮及其代谢物的液相色谱-串联质谱分析及其在雄性Sprague-Dawley大鼠药代动力学研究中的应用。
Xenobiotica. 2002 Feb;32(2):141-51. doi: 10.1080/00498250110091767.
8
The development of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-β-glucuronide, morphine-6-β-glucuronide, hydromorphone, and normorphine in serum.一种用于同时定量血清中吗啡、吗啡-3-β-葡糖苷酸、吗啡-6-β-葡糖苷酸、氢吗啡酮和去甲吗啡的高效液相色谱-串联质谱法的开发。
Clin Biochem. 2015 Dec;48(18):1283-90. doi: 10.1016/j.clinbiochem.2015.05.023. Epub 2015 Jun 26.
9
Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient.
Xenobiotica. 2002 May;32(5):427-39. doi: 10.1080/00498250110119090.
10
Pain management in chronic kidney disease: the pharmacokinetics and pharmacodynamics of hydromorphone and hydromorphone-3-glucuronide in hemodialysis patients.慢性肾脏病的疼痛管理:血液透析患者中氢吗啡酮及氢吗啡酮-3-葡萄糖醛酸苷的药代动力学和药效学
J Opioid Manag. 2008 Nov-Dec;4(6):335-6, 339-44.

引用本文的文献

1
Morphine and hydromorphone pharmacokinetics in human volunteers: population-based modelling of interindividual and opioid-related variability.吗啡和氢吗啡酮在人类志愿者中的药代动力学:基于群体的个体间和阿片类药物相关变异性建模。
Br J Anaesth. 2025 Feb;134(2):358-367. doi: 10.1016/j.bja.2024.08.042. Epub 2024 Nov 26.
2
Hydromorphone Prescription for Pain in Children-What Place in Clinical Practice?儿童疼痛的氢吗啡酮处方——在临床实践中的地位如何?
Front Pediatr. 2022 Apr 25;10:842454. doi: 10.3389/fped.2022.842454. eCollection 2022.
3
Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.
预测药物-宏基因组相互作用:人类肠道宏基因组中微生物β-葡萄糖醛酸酶水平的变化。
PLoS One. 2021 Jan 7;16(1):e0244876. doi: 10.1371/journal.pone.0244876. eCollection 2021.
4
Relationship between plasma concentrations of morphine and its metabolites and pain in cancer patients.癌症患者血浆中吗啡及其代谢物浓度与疼痛之间的关系。
Pharm World Sci. 2010 Dec;32(6):737-43. doi: 10.1007/s11096-010-9430-9. Epub 2010 Aug 21.
5
OROS hydromorphone prolonged release: a review of its use in the management of chronic, moderate to severe pain.奥施康定(羟考酮控释片):用于治疗慢性中重度疼痛的综述。
CNS Drugs. 2010 Apr;24(4):337-61. doi: 10.2165/11202580-000000000-00000.
6
Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.鞘内注射吗啡-3-葡糖苷酸可能通过 Toll 样受体 4/MD-2 和白细胞介素-1β引起疼痛增强的证据。
Neuroscience. 2010 Jan 20;165(2):569-83. doi: 10.1016/j.neuroscience.2009.10.011.
7
Opioid metabolism.阿片类药物代谢
Mayo Clin Proc. 2009 Jul;84(7):613-24. doi: 10.1016/S0025-6196(11)60750-7.
8
Pediatric palliative care: use of opioids for the management of pain.儿科姑息治疗:使用阿片类药物管理疼痛。
Paediatr Drugs. 2009;11(2):129-51. doi: 10.2165/00148581-200911020-00004.
9
Direct MS-MS identification of isoxsuprine-glucuronide in post-administration equine urine.给药后马尿液中异克舒令 - 葡萄糖醛酸苷的直接串联质谱鉴定
Can J Vet Res. 2000 Apr;64(2):112-6.